Press Releases
ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT™
read more ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT™
Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform
read more Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform
ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023
read more ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023
ProBioGen’s Growth Strategy Continues Successfully
read more ProBioGen’s Growth Strategy Continues Successfully
Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
read more Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
read more ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
read more ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
read more ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
